의료 데이터 수익화 시장 : 데이터 유형별, 수익화 모델별, 용도별, 최종사용자별 - 세계 예측(-2036년)

Healthcare Data Monetization Market by Data Type (Clinical Data, Claims & Financial Data, Pharmaceutical & R&D Data, Patient-Generated Data, Operational & Administrative Data), Monetization Model (Internal Monetization, External Monetization), Application, and End User - Global Forecast to 2036

According to the research report titled, 'Healthcare Data Monetization Market by Data Type (Clinical Data, Claims & Financial Data, Pharmaceutical & R&D Data, Patient-Generated Data, Operational & Administrative Data), Monetization Model (Internal Monetization, External Monetization), Application, and End User - Global Forecast to 2036,' the global healthcare data monetization market is expected to reach approximately USD 28.7 billion by 2036 from USD 569.7 million in 2026, at a CAGR of 17.6% during the forecast period (2026-2036). The report provides an in-depth analysis of the global healthcare data monetization market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036.

Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The major factors driving the growth of the healthcare data monetization market include the intensifying global focus on data-driven care delivery and the rapid expansion of artificial intelligence adoption. Additionally, the integration of privacy-enhancing technologies, increasing demand for high-quality health datasets, and expansion of federated data networks are expected to create significant growth opportunities for players operating in the healthcare data monetization market.

Market Segmentation

The healthcare data monetization market is segmented by data type (clinical data, claims & financial data, pharmaceutical & R&D data, patient-generated data, operational & administrative data), monetization model (internal monetization, external monetization), application, and end user. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Data Type

By data type, the clinical data segment holds the largest market share in 2026, primarily attributed to the breadth and depth of structured and unstructured clinical records generated across hospitals and ambulatory care settings globally. Clinical data represents the most commercially valuable health data asset. However, the pharmaceutical & R&D data segment is expected to grow at the fastest CAGR during the forecast period, driven by the increasing demand for real-world clinical datasets to accelerate candidate identification and support regulatory submissions. Claims & financial data, patient-generated data, and operational & administrative data represent specialized segments with rapid growth potential.

Based on Monetization Model

By monetization model, the external monetization segment holds the largest market share in 2026, owing to the high commercial demand for licensed health datasets and data-as-a-service offerings from pharmaceutical, biotechnology, and research organizations. External monetization represents the primary revenue driver for healthcare data companies. The internal monetization segment is expected to witness significant growth during the forecast period, driven by healthcare organizations seeking to unlock strategic value from their proprietary data assets and improve operational efficiency.

Based on Application

By application, the drug discovery and development segment holds the largest share of the overall market in 2026, as pharmaceutical companies increasingly rely on real-world clinical datasets to accelerate candidate identification and support regulatory submissions. Drug discovery represents the most established application for health data monetization. Real-world evidence generation, precision medicine, and population health management represent emerging applications with significant growth potential.

Based on End User

By end user, the pharmaceutical and biotechnology companies segment holds the largest share of the overall market in 2026, reflecting their sustained demand for high-quality health datasets to support drug development and clinical research. Pharmaceutical and biotechnology companies represent the primary market driver. Healthcare providers, payers, research institutions, and other end-user segments represent emerging markets with rapid growth potential.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. In 2026, North America dominates the global healthcare data monetization market with the largest market share, primarily attributed to a mature health information technology infrastructure and high electronic health record adoption rates in the United States and Canada. Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by rapid digitization of healthcare systems and government-backed national health data initiatives in China, India, Japan, and Southeast Asia. Europe, Latin America, and the Middle East & Africa represent emerging markets with growing emphasis on data-driven healthcare and real-world evidence programs.

Key Players

The key players operating in the global healthcare data monetization market are IQVIA Holdings Inc., Optum Inc., Inovalon Holdings Inc., Komodo Health Inc., Datavant Inc., Flatiron Health (Roche), Tempus AI, Veradigm LLC, and various other regional and emerging health data analytics and data monetization service providers, among others.

Key Questions Answered in the Report-

• What is the current revenue generated by the healthcare data monetization market globally?
• At what rate is the global healthcare data monetization market demand projected to grow for the next 7-10 years?
• What are the historical market sizes and growth rates of the global healthcare data monetization market?
• What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
• Which segments in terms of data type, monetization model, application, and end user are expected to create major traction for the service providers in this market?
• What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global healthcare data monetization market?
• Who are the major players in the global healthcare data monetization market? What are their specific product offerings in this market?
• What are the recent strategic developments in the global healthcare data monetization market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Healthcare Data Monetization Market Assessment -- by Data Type

• Clinical Data
• Claims & Financial Data
• Pharmaceutical & R&D Data
• Patient-Generated Data
• Operational & Administrative Data

Healthcare Data Monetization Market Assessment -- by Monetization Model

• Internal Monetization
• External Monetization

Healthcare Data Monetization Market Assessment -- by Application

• Drug Discovery and Development
• Real-World Evidence Generation
• Precision Medicine
• Population Health Management
• Others

Healthcare Data Monetization Market Assessment -- by End User

• Pharmaceutical and Biotechnology Companies
• Healthcare Providers
• Payers
• Research Institutions
• Others

Healthcare Data Monetization Market Assessment -- by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Scope
• 1.3. Research Methodology
• 1.4. Assumptions & Limitations

2. Executive Summary

3. Market Overview

• 3.1. Introduction
• 3.2. Market Dynamics
  • 3.2.1. Drivers
  • 3.2.2. Restraints
  • 3.2.3. Opportunities
  • 3.2.4. Challenges
• 3.3. Impact of AI and Cloud Technologies on Healthcare Data Monetization
• 3.4. Regulatory Landscape & Data Privacy Frameworks
• 3.5. Porter's Five Forces Analysis

4. Global Healthcare Data Monetization Market, by Data Type

• 4.1. Introduction
• 4.2. Clinical Data
  • 4.2.1. Electronic Health Records (EHR) Data
  • 4.2.2. Medical Imaging Data
  • 4.2.3. Laboratory & Diagnostic Data
• 4.3. Claims & Financial Data
  • 4.3.1. Insurance Claims Data
  • 4.3.2. Billing & Reimbursement Data
• 4.4. Pharmaceutical & R&D Data
  • 4.4.1. Clinical Trial Data
  • 4.4.2. Drug Utilization & Outcomes Data
• 4.5. Patient-Generated Data
  • 4.5.1. Wearable & Remote Monitoring Data
  • 4.5.2. Consumer Health Application Data
• 4.6. Operational & Administrative Data
  • 4.6.1. Workforce & Scheduling Data
  • 4.6.2. Supply Chain & Procurement Data

5. Global Healthcare Data Monetization Market, by Monetization Model

• 5.1. Introduction
• 5.2. Internal Monetization
  • 5.2.1. Operational Efficiency & Cost Reduction
  • 5.2.2. Clinical Performance Improvement
• 5.3. External Monetization
  • 5.3.1. Data Licensing & Data-as-a-Service (DaaS)
  • 5.3.2. Research & Analytics Partnerships
  • 5.3.3. Real-World Data Marketplaces

6. Global Healthcare Data Monetization Market, by Application

• 6.1. Introduction
• 6.2. Drug Discovery & Development
• 6.3. Clinical Trials Management
• 6.4. Population Health Management
• 6.5. Revenue Cycle Management
• 6.6. Precision Medicine
• 6.7. Healthcare Operations Optimization

7. Global Healthcare Data Monetization Market, by End User

• 7.1. Introduction
• 7.2. Pharmaceutical & Biotechnology Companies
  • 7.2.1. Large Pharmaceutical Companies
  • 7.2.2. Specialty Pharma & Biotech Firms
• 7.3. Healthcare Providers
  • 7.3.1. Hospital Systems & Integrated Delivery Networks
  • 7.3.2. Ambulatory & Specialty Care Providers
• 7.4. Payers
  • 7.4.1. Commercial Health Insurers
  • 7.4.2. Government & Public Payers
• 7.5. Medical Device Manufacturers
  • 7.5.1. Diagnostic Device Companies
  • 7.5.2. Digital Health & Wearable Device Companies
• 7.6. Healthcare IT Companies
  • 7.6.1. EHR & Health Information System Vendors
  • 7.6.2. Health Analytics Platform Providers
• 7.7. Government & Research Institutions
  • 7.7.1. Academic Medical Centers
  • 7.7.2. Public Health Agencies & National Research Bodies

8. Global Healthcare Data Monetization Market, by Region

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. U.S.
  • 8.2.2. Canada
• 8.3. Europe
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. U.K.
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Netherlands
  • 8.3.7. Rest of Europe
• 8.4. Asia-Pacific
  • 8.4.1. China
  • 8.4.2. India
  • 8.4.3. Japan
  • 8.4.4. South Korea
  • 8.4.5. Southeast Asia
  • 8.4.6. Australia
  • 8.4.7. Rest of Asia-Pacific
• 8.5. Latin America
  • 8.5.1. Brazil
  • 8.5.2. Mexico
  • 8.5.3. Rest of Latin America
• 8.6. Middle East & Africa
  • 8.6.1. Saudi Arabia
  • 8.6.2. UAE
  • 8.6.3. South Africa
  • 8.6.4. Rest of Middle East & Africa

9. Competitive Landscape

• 9.1. Overview
• 9.2. Key Growth Strategies
• 9.3. Competitive Benchmarking
• 9.4. Competitive Dashboard
  • 9.4.1. Industry Leaders
  • 9.4.2. Market Differentiators
  • 9.4.3. Vanguards
  • 9.4.4. Emerging Companies
• 9.5. Market Ranking / Positioning Analysis of Key Players, 2025

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, SWOT Analysis)

• 10.1. IQVIA Holdings Inc.
• 10.2. Optum Inc. (UnitedHealth Group)
• 10.3. Oracle Health (formerly Cerner Corporation)
• 10.4. Merative (formerly IBM Watson Health)
• 10.5. Komodo Health Inc.
• 10.6. Inovalon Holdings Inc.
• 10.7. Datavant Inc.
• 10.8. Definitive Healthcare Corp.
• 10.9. Veeva Systems Inc.
• 10.10. Flatiron Health Inc. (Roche Group)
• 10.11. Health Catalyst Inc.
• 10.12. Innovaccer Inc.

11. Appendix

• 11.1. Questionnaire
• 11.2. Related Reports